CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Study of Mifepristone in Combination With Eribulin in Patients With Locally Advanced/Metastatic Breast or Other Specified Solid Tumors, With a Dose Expansion Cohort in Patients With Triple Negative Breast Cancer.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02014337
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:42.215983+00:00
Published At: 2018-01-17T00:00:00+00:00
Record Updated At: 2018-01-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Ovarian Epithelial Cancer Recurrent", "Sarcoma", "Non-small Cell Lung Cancer", "Carcinoma, Transitional Cell", "Prostate Cancer", "Prostatic Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-01-17"
protocolSection.identificationModule.nctId: "NCT02014337"
protocolSection.identificationModule.officialTitle: "Phase 1 Study of Mifepristone in Combination With Eribulin in Patients With Locally Advanced/Metastatic Breast or Other Specified Solid Tumors, With a Dose Expansion Cohort in Patients With Triple Negative Breast Cancer."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.